Search research articles
Contact Us
Filters
Showing results (81-90 of 488) with videos related to
Page
of 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel
Hans Gelderblom, Jaap Verweij, Desirée M van Zomeren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2018
Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events
Dirk H Wijn, Geert H Groeneveld, Albert M Vollaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer
Vincent O Dezentjé, Henk-Jan Guchelaar, Johan W R Nortier, et al.
Hematology/Oncology Clinics of North America
|
October 8, 2013
Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma
Jolieke G van Oosterwijk, Jakob K Anninga, Hans Gelderblom, et al.
Cancer Cell
|
June 11, 2024
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, et al.
Cancer Biology & Therapy
|
May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecan
Alex Sparreboom, Walter J Loos, Herman Burger, et al.
Frontiers in Pharmacology
|
October 29, 2020
Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review
Emma C Hulshof, Lifani Lim, Ignace H J T de Hingh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2016
Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway
Annemiek M van Maldegem, Judith V M G Bovée, Elleke F P Peterse, et al.
Sarcoma
|
August 2, 2021
Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000-2017 Netherlands Cancer Registry Database Analysis
Milan Van Meekeren, Marta Fiocco, Vincent K Y Ho, et al.
Anti-Cancer Drugs
|
March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis
Walter J Loos, Hans Gelderblom, Jaap Verweij, et al.
Page
of 49
Search research articles
Search
Showing results (81-90 of 488) with videos related to
Sort By:
Page
of 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel
Hans Gelderblom, Jaap Verweij, Desirée M van Zomeren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2018
Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events
Dirk H Wijn, Geert H Groeneveld, Albert M Vollaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2009
Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer
Vincent O Dezentjé, Henk-Jan Guchelaar, Johan W R Nortier, et al.
Hematology/Oncology Clinics of North America
|
October 8, 2013
Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma
Jolieke G van Oosterwijk, Jakob K Anninga, Hans Gelderblom, et al.
Cancer Cell
|
June 11, 2024
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug development
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, et al.
Cancer Biology & Therapy
|
May 24, 2005
Effect of ABCG2 genotype on the oral bioavailability of topotecan
Alex Sparreboom, Walter J Loos, Herman Burger, et al.
Frontiers in Pharmacology
|
October 29, 2020
Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review
Emma C Hulshof, Lifani Lim, Ignace H J T de Hingh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2016
Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway
Annemiek M van Maldegem, Judith V M G Bovée, Elleke F P Peterse, et al.
Sarcoma
|
August 2, 2021
Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000-2017 Netherlands Cancer Registry Database Analysis
Milan Van Meekeren, Marta Fiocco, Vincent K Y Ho, et al.
Anti-Cancer Drugs
|
March 14, 2003
Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis
Walter J Loos, Hans Gelderblom, Jaap Verweij, et al.
Page
of 49